Summit Partners Public Asset Management LLC Takes Position in Billiontoone, Inc. $BLLN

Summit Partners Public Asset Management LLC purchased a new position in Billiontoone, Inc. (NASDAQ:BLLN) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 19,783 shares of the company’s stock, valued at approximately $1,619,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Baillie Gifford & Co. purchased a new stake in Billiontoone in the 4th quarter valued at about $103,786,000. Massachusetts Financial Services Co. MA purchased a new stake in Billiontoone in the 4th quarter valued at about $13,373,000. Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in Billiontoone in the 4th quarter valued at about $1,348,000. UBS Group AG purchased a new stake in Billiontoone in the 4th quarter valued at about $2,586,000. Finally, Adams Street Partners LLC purchased a new stake in Billiontoone in the 4th quarter valued at about $140,063,000.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on BLLN shares. BTIG Research lowered their price objective on shares of Billiontoone from $140.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. Guggenheim upped their price objective on shares of Billiontoone from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. Wall Street Zen raised shares of Billiontoone from a “hold” rating to a “buy” rating in a research note on Saturday, March 7th. Wells Fargo & Company lowered their price objective on shares of Billiontoone from $110.00 to $90.00 and set an “equal weight” rating for the company in a research note on Thursday, March 5th. Finally, Weiss Ratings lowered shares of Billiontoone from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, June 5th. Six investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Billiontoone presently has a consensus rating of “Moderate Buy” and an average price target of $125.29.

Billiontoone Stock Down 3.1%

NASDAQ:BLLN opened at $100.70 on Wednesday. The firm has a market cap of $4.63 billion and a PE ratio of 183.09. The company has a 50-day moving average of $88.95 and a 200 day moving average of $87.60. Billiontoone, Inc. has a 1-year low of $61.96 and a 1-year high of $138.70. The company has a debt-to-equity ratio of 0.18, a current ratio of 10.92 and a quick ratio of 10.58.

Billiontoone (NASDAQ:BLLN) last released its quarterly earnings results on Wednesday, May 6th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.01 by $0.33. The firm had revenue of $108.39 million for the quarter, compared to analysts’ expectations of $95.81 million. The business’s quarterly revenue was up 83.8% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.39) earnings per share. As a group, research analysts anticipate that Billiontoone, Inc. will post 0.93 EPS for the current fiscal year.

Insider Activity at Billiontoone

In related news, insider Shan Riku Sakakibara sold 8,000 shares of the stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $98.22, for a total value of $785,760.00. Following the completion of the transaction, the insider directly owned 212,000 shares of the company’s stock, valued at $20,822,640. This trade represents a 3.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nancy Joann Johnson sold 10,582 shares of the stock in a transaction that occurred on Tuesday, June 9th. The shares were sold at an average price of $100.47, for a total transaction of $1,063,173.54. Following the completion of the transaction, the insider directly owned 21,900 shares of the company’s stock, valued at $2,200,293. The trade was a 32.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 60,750 shares of company stock valued at $5,979,598 in the last three months.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.